Thynk Capital

Thynk Capital is a venture capital firm that backs early-stage therapeutics, healthcare and technology companies. Its current emphasis is pharma and biotech firms working to extend healthy lifespan and treat diseases of ageing.

What Thynk Capital does

• Early-stage capital: growth funding for young companies.
• Operational help: work with management teams to improve efficiency and strengthen leadership.
• Strategy: roadmaps for steady growth aimed at large markets.
• Industry involvement: participation in industry bodies, regulatory work and advanced research studies.

Customers and markets

Its pharma and biotech interest covers Alzheimer's, dementia, kidney disease, cancer, cardiovascular disease, diabetes, frailty and rare disease. It also invests in technology companies and reports to limited partners.

Key facts

• Stage: Early-stage
• Sectors: Therapeutics, healthcare and technology
• Focus: Human longevity and healthspan